We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...
Citi reiterated a Buy rating and $1,190 price target on Eli Lilly (LLY), saying the firm expects a positive read-through to the shares on FDA’s ...
FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...
AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.
Walmart, Eli Lilly and Company, Intuitive Surgical, UnitedHealth Group, and Abbott Laboratories are the five Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical ...
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
6d
MedPage Today on MSNBrain Edema, Imaging Abnormalities Reported for Alzheimer's DrugTreatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...
A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results